Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Immune changes and specific genes contribute to male hair loss.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

The research provides a gene-based framework for hair biology, highlighting the Hippo pathway's importance and suggesting links between hair disorders, cancer pathways, and the immune system.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

New technologies help us better understand how skin microbes affect skin diseases.

The study found that the hair loss condition in Cesky Fousek dogs is influenced by multiple genes affecting skin and muscle structure, fat metabolism, and immunity.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Potential therapeutic targets for scarring hair loss are identified.

The research provides insights into hair follicle growth in forest musk deer by identifying key genes and pathways involved.

EGFR deficiency in skin causes hair follicle issues and inflammation.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

CRISPR/Cas9 gene-editing may effectively treat hair loss but requires more research for safe use.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Cyclosporin is effective in treating dog skin diseases and has fewer side effects compared to other treatments.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Netherton syndrome can cause severe dehydration, infections, and growth issues in infants.